Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 2
1990 2
1991 2
1992 3
1993 7
1994 2
1995 4
1997 4
1998 3
1999 6
2000 10
2001 9
2002 15
2003 18
2004 28
2005 27
2006 24
2007 15
2008 26
2009 18
2010 8
2011 27
2012 18
2013 18
2014 25
2015 17
2016 22
2017 21
2018 14
2019 27
2020 31
2021 29
2022 32
2023 22
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

490 results

Results by year

Filters applied: . Clear all
Page 1
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.
Numakura K, Kobayashi M, Muto Y, Sato H, Sekine Y, Sobu R, Aoyama Y, Takahashi Y, Okada S, Sasagawa H, Narita S, Kumagai S, Wada Y, Mori N, Habuchi T. Numakura K, et al. Among authors: habuchi t. Curr Oncol. 2023 Sep 1;30(9):8092-8110. doi: 10.3390/curroncol30090587. Curr Oncol. 2023. PMID: 37754502 Free PMC article. Review.
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study.
Shiota M, Tatarano S, Kamoto T, Matsuyama H, Sakai H, Igawa T, Kamba T, Fujimoto N, Sekine Y, Kimura H, Narita S, Terada N, Momozawa Y, Akamatsu S, Habuchi T, Yokomizo A, Naito S, Eto M. Shiota M, et al. Among authors: habuchi t. Endocr Relat Cancer. 2023 Jun 1;30(7):e230044. doi: 10.1530/ERC-23-0044. Print 2023 Jul 1. Endocr Relat Cancer. 2023. PMID: 37079309
[A Case of Renal Anastomosing Hemangioma].
Sasaki Y, Kashima S, Koyama T, Hiroshima Y, Amano K, Takahashi S, Nara T, Koizumi A, Yamamoto R, Numakura K, Saito M, Narita S, Nanjo H, Satoh S, Habuchi T. Sasaki Y, et al. Among authors: habuchi t. Hinyokika Kiyo. 2022 Aug;68(8):265-269. doi: 10.14989/ActaUrolJap_68_8_265. Hinyokika Kiyo. 2022. PMID: 36071018 Free article. Japanese.
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.
Kimura H, Mizuno K, Shiota M, Narita S, Terada N, Fujimoto N, Ogura K, Hatano S, Iwasaki Y, Hakozaki N, Ishitoya S, Sumiyoshi T, Goto T, Kobayashi T, Nakagawa H, Kamoto T, Eto M, Habuchi T, Ogawa O, Momozawa Y, Akamatsu S. Kimura H, et al. Among authors: habuchi t. Br J Cancer. 2022 Nov;127(9):1680-1690. doi: 10.1038/s41416-022-01915-2. Epub 2022 Aug 19. Br J Cancer. 2022. PMID: 35986085 Free PMC article.
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Yanagisawa T, Hata K, Narita S, Hatakeyama S, Mori K, Yata Y, Sano T, Otsuka T, Hara S, Miyajima K, Enei Y, Fukuokaya W, Nakazono M, Matsukawa A, Miki J, Habuchi T, Ohyama C, Shariat SF, Kimura T. Yanagisawa T, et al. Among authors: habuchi t. Prostate. 2023 May;83(6):563-571. doi: 10.1002/pros.24488. Epub 2023 Jan 20. Prostate. 2023. PMID: 36661102
Management of prostate cancer in older patients.
Narita S, Hatakeyama S, Sakamoto S, Kato T, Inokuchi J, Matsui Y, Kitamura H, Nishiyama H, Habuchi T. Narita S, et al. Among authors: habuchi t. Jpn J Clin Oncol. 2022 May 31;52(6):513-525. doi: 10.1093/jjco/hyac016. Jpn J Clin Oncol. 2022. PMID: 35217872
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group.
Horie S, Naito S, Hatakeyama S, Kandori S, Numakura K, Kato R, Koguchi T, Myoen S, Kawasaki Y, Ito A, Adachi H, Kojima Y, Obara W, Habuchi T, Nishiyama H, Ohyama C, Tsuchiya N. Horie S, et al. Among authors: habuchi t. Int J Clin Oncol. 2023 Nov;28(11):1538-1544. doi: 10.1007/s10147-023-02401-2. Epub 2023 Sep 22. Int J Clin Oncol. 2023. PMID: 37740070
Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Fujiyama N, Tasaki M, Harada H, Tsutahara K, Matsumoto A, Kamijo Y, Toyoda M, Iwami D, Inui M, Shirakawa H, Sugimura J, Saito M, Hotta K, Okumi M, Saito K, Watarai Y, Hidaka Y, Ohtani K, Inoue N, Wakamiya N, Habuchi T, Satoh S; Japanese Post-kidney Transplant TMA Support Team. Fujiyama N, et al. Among authors: habuchi t. Clin Exp Nephrol. 2023 Dec;27(12):1010-1020. doi: 10.1007/s10157-023-02391-5. Epub 2023 Aug 27. Clin Exp Nephrol. 2023. PMID: 37634218
490 results